UBS Group’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Hold
25,000
﹤0.01% 5325
2026
Q1
$1.89M Buy
+25,000
New +$1.78M ﹤0.01% 5026
2025
Q2
Sell
-9,700
Closed -$482K 10659
2025
Q1
$482K Buy
+9,700
New +$496K ﹤0.01% 5879
2023
Q4
Sell
-47,100
Closed -$2.91M 9720
2023
Q3
$2.91M Hold
47,100
﹤0.01% 3088
2023
Q2
$2.78M Buy
+47,100
New +$3M ﹤0.01% 3205
2022
Q2
Sell
-192,194
Closed -$20M 10724
2022
Q1
$20M Buy
+192,194
New +$15.9M 0.01% 1419

Other funds holding NTR

UBS Group's NTR Position: Q2 2026 in Review

UBS Group reduced its Nutrien (NTR) stake by 1.3% in Q2 2026, selling an estimated $944K and leaving 1,065,052 shares worth $67M. The position accounts for 0.01% of the portfolio, ranked #1468.

UBS Group first reported a position in NTR in Q1 2018 and has held it in 34 quarters since. The position peaked at $128M in Q1 2022. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • UBS Group held 1,065,052 shares of Nutrien worth $67M as of Q2 2026.
  • UBS Group sold 13,505 Nutrien shares in Q2 2026, an estimated $944K.
  • Nutrien made up 0.01% of UBS Group's portfolio in Q2 2026, its #1468 holding.
  • UBS Group first reported a position in Nutrien in Q1 2018 and has held it in 34 quarters since.
  • UBS Group's Nutrien position peaked at $128M in Q1 2022.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.